1. India Stocks

  2. •

    Miscellaneous

  3. •

    Miscellaneous
Ajooni Biotech Limited

Ajooni Biotech Limited

NNSE:AJOONI
2.94
INR
+0.07
(+2.44%)
0.22EPS
25.36P/E
964.56MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.14
1.72
3.16
6.82
10.13
9.06
7.41
7.93
11.39
99.84
8.06
6.66
10.59
7.54
Basic EPS, GAAP
- -
0.02
0.02
0.07
0.09
0.09
0.06
0.06
0.16
1.51
0.22
0.2
0.25
0.22
Free Cash Flow per Basic Share
-0.04
-0.01
-0.19
-0.4
- -
-1.12
-1.07
-0.37
0.24
-13.13
2.31
-1.86
-0.33
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.08
0.1
0.12
0.23
2.62
2.77
2.65
2.43
2.55
4.19
4.3
5.11
5.29
5.11
Tangible Book Value per Share
0.08
0.1
0.12
0.23
2.62
2.77
2.65
2.43
2.55
4.19
4.3
5.09
5.27
5.09
Basic Weighted Avg Shares
42
42
42
42
42
44
54
64
65
7
99
172
172
152
Sales/Revenue/Turnover
6
72
132
285
424
397
400
510
740
745
801
1,147
1,824
1,147
Operating Margin (%)
2.16
1.44
1.21
1.66
1.94
1.03
2.22
2.38
3
2.37
1.89
2.53
2.29
2.54
Depreciation Expense
- -
- -
1
2
3
4
4
4
10
10
9
11
22
11
Net Income, GAAP
- -
1
1
3
4
4
3
4
10
11
22
34
43
34
Effective Tax Rate (%)
33.04
31
31.51
28.83
20.87
13.47
27.86
26.02
28.22
28.68
27.87
22.11
24.68
22.68
Profit Margin (%)
1.35
1.01
0.73
0.97
0.91
1.03
0.87
0.73
1.42
1.51
2.7
2.94
2.37
2.93
Working Capital
2
2
4
-22
52
99
117
110
119
195
293
565
466
565
LT Debt
- -
- -
2
6
3
42
13
19
26
17
17
13
10
13
Total Equity
4
4
5
10
109
122
159
156
164
417
427
881
912
881
Return on Invested Capital (%)
4.28
18.86
12.5
10
5.04
1.41
2.82
3.62
6.3
3.61
4.37
2.97
3.1
3.3
Return on Capital (%)
4.28
18.86
12.5
9.86
6.06
3.13
3.03
3.41
6.51
4.25
5.58
5.35
4.88
5.32
Return on Common Equity (%)
4.28
18.72
20.38
36.98
6.48
3.56
2.47
2.37
6.55
3.87
5.12
5.16
4.82
5.14

Capital Structure

INR

•

in mil. unless spec.
Sep'25
Dec'25
Mar'25
ST Debt
- -
- -
7
LT Borrowings
22
21
13
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
172
172
172
Market Capitalization
1,426
1,338
965

Working Capital

INR

•

in mil. unless spec.
Sep'25
Dec'25
Mar'25
Total Current Assets
714
751
620
Cash, Cash Equivalents & STI
170
176
75
Accounts Receivable, Net
233
218
162
Inventories
170
209
240
Total Current Liabilities
6
41
55
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
7
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
142.61%
54.3%
3.53%
Free Cash Flow
- -
-309.89%
-82.07%
Net Income, GAAP
58.89%
72.95%
28.16%
Sales/Revenue/Turnover
34.16%
31.08%
59.02%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
210
195
201
196
801
2025
257
257
340
293
1,147
2026
- -
- -
- -
- -
1,824

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.04
0.23
0.04
0.09
0.22
2025
0.05
0.04
0.04
0.09
0.2
2026
- -
- -
- -
- -
0.25

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Jasjot Singh
Full Time Employees
182
Sector
Miscellaneous
Industry
Miscellaneous
Address
House No. 1769 Mohali PU India 160055
IPO Date
Jan 2, 2018
Website
ajoonibiotech.com
Similar Companies
X5 Corporate Center (MOEX:X5)
CID HoldCo, Inc. (NASDAQ:DAIC)
Borusan Yatirim ve Pazarlama AS (BIST:BRYAT)
PASIFIK HOLDING A.S (BIST:PAHOL)
PT Indokripto Koin Semesta Tbk (IDX:COIN)
PT Raharja Energi Cepu Tbk (IDX:RATU)
Business
Ajooni Biotech Limited is a biotechnology company specializing in the manufacturing, processing, and supply of animal feed and animal health care supplements in India. The company offers a comprehensive portfolio of products including pure vegetarian cattle feed, cattle feed chips, camel feed, pig feed, cotton oil cake, mustard oil cake, and a wide range of feed supplements to cover the entire life cycle of animals. Its feed supplements include branded formulations such as CALTUS, 4U, LIVTUS, RUMITUS, Mustmin, AUTOVITA, as well as products for oral calcium, bloating, calcium gel, mastitis powder, mineral mixtures, liver tonics, milk gainers, multivitamins, growth promoters, foot and mouth disease powder, and heat stock powder. Ajooni Biotech integrates advanced technologies including ERP and PLC systems in its manufacturing processes and operates state-of-the-art in-house testing laboratories ensuring rigorous quality control. Founded in 2010 and headquartered in Mohali, Punjab, the company has positioned itself strongly within the Indian livestock and aquaculture markets. In the past two years, Ajooni Biotech has undertaken significant operational expansions, including the launch of a new manufacturing facility in Khanna with a production capacity of 120,000 metric tonnes, operational from late 2025. The company secured a major cattle feed supply contract worth ₹27 crores, reinforcing its market position and growth trajectory. These developments reflect Ajooni’s strategic focus on scaling production capabilities and increasing revenue streams. The company continues to leverage its expertise and technical support services, providing around-the-clock veterinary and livestock nutrition advisory to customers. Its growth is supported by quality-focused innovations and expanding operational infrastructure designed to meet rising market demand for compounded animal feeds and health supplements in India. Ajooni Biotech operates predominantly within India, serving a broad customer base including livestock farmers and aquaculture professionals. The company’s emphasis on producing pure vegetarian products aligns with market preferences and regulatory frameworks. Its integration of technology, stringent quality standards, and expanding facilities underscore its ambition to become a leading player in the animal feed sector. This description includes the company’s main products and services as well as recent major changes such as the new manufacturing facility and significant contract wins, providing an up-to-date and comprehensive profile of Ajooni Biotech Limited.